摘要
目的:探讨18F-脱氧葡萄糖(18F-FDG)PET心肌显像与冠状动脉CT血管造影(CTA)相结合提高冠心病临床诊断水平,规范化应用冠心病诊断处理技术。方法:使用正电子核素药物18F-FDG对35例确诊为冠心病患者进行心肌代谢显像和冠状动脉CTA检查,对所有患者行18F-FDG PET心肌显像与冠状动脉CTA相结合检查结果与确诊病例结果进行比较。结果:18F-FDG PET心肌显像与冠状动脉CTA相结合诊断冠心病的灵敏度、特异度分别为100%和96%。结论:将18F-FDG PET数据与冠状动脉CTA数据进行精确融合,得到的精确融合图像,既可提供反映冠状动脉解剖的指标,又可提供反映心肌病理生理及代谢的指标,各项指标之间可互相印证和补充。
Objective： To investigate the 18F-FDG PET myocardial scintigraphy and Coronary CT angiography（CTA） combination improve coronary heart disease clinical diagnosis level, and the diagnosis of coronary heart disease treatment technology of standardization for clinical application. Methods： The use of positron radionuclide drug 18^F- fluorodeoxyglucose（18F-FDG） was made in 35 patients with myocardial metabolic imaging of coronary arteries and CTA examination, 20 patients with myocardial infarction patients, the FDG PET myocardial scintigraphy and coronary artery CTA combine examination results and confirmed case comparison of results. Results： 18^F-FDG PETmyocardial scintigraphy and coronary artery CTA combination in the diagnosis of coronary heart disease, sensitivity and specificity of 100% and 96%. Conclusion： 18^F-FDG PET data and coronary artery CTA precision data fusion, the fusion image is accurate, can not only provide clinicians reflect coronary artery anatomy indicators, can also provide reflect myocardial pathological physiology and metabolism index, to verify and supplement each other between the indicators.
出处
《中国医学装备》
2015年第2期68-70,共3页
China Medical Equipment
